| (-)-anisomycin | increases expression | ISO | RGD:1305285 | 6480464 | Anisomycin results in increased expression of POSTN mRNA | CTD | PMID:15121739 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1305285 | 6480464 | Ethinyl Estradiol results in decreased expression of POSTN mRNA | CTD | PMID:17557909 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1305285 | 6480464 | Ethinyl Estradiol results in decreased expression of POSTN mRNA | CTD | PMID:12075121 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1305285 | 6480464 | Ethinyl Estradiol results in decreased expression of POSTN mRNA | CTD | PMID:17351261 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1305285 | 6480464 | Ethinyl Estradiol results in decreased expression of POSTN mRNA | CTD | PMID:17557909 more ... |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of POSTN mRNA | CTD | PMID:17555576 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | EXP | | 6480464 | Dihydrotestosterone results in decreased expression of POSTN mRNA | CTD | PMID:17023530 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of POSTN mRNA] | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POSTN mRNA | CTD | PMID:21889950 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of POSTN mRNA | CTD | PMID:20713471 |
| 5-fluorouracil | decreases response to substance | ISO | RGD:1313223 | 6480464 | POSTN protein results in decreased susceptibility to Fluorouracil | CTD | PMID:15731169 |
| aflatoxin B1 | affects expression | ISO | RGD:1313223 | 6480464 | Aflatoxin B1 affects the expression of POSTN protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1313223 | 6480464 | Aflatoxin B1 results in increased expression of POSTN mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313223 | 6480464 | Tretinoin results in increased expression of POSTN mRNA | CTD | PMID:21934132 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of POSTN mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of POSTN mRNA | CTD | PMID:21964900 |
| benzo[a]pyrene | increases expression | ISO | RGD:1313223 | 6480464 | Benzo(a)pyrene results in increased expression of POSTN mRNA | CTD | PMID:22316170 |
| bisphenol A | decreases expression | ISO | RGD:1305285 | 6480464 | bisphenol A results in decreased expression of POSTN mRNA | CTD | PMID:12075121 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA | CTD | PMID:20938992 |
| copper atom | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA | CTD | PMID:15467011 |
| copper(0) | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA | CTD | PMID:15467011 |
| curcumin | increases expression | ISO | RGD:1313223 | 6480464 | Curcumin results in increased expression of POSTN mRNA | CTD | PMID:21594647 |
| cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of POSTN mRNA | CTD | PMID:15331540 |
| cytarabine | decreases expression | ISO | RGD:1313223 | 6480464 | Cytarabine results in decreased expression of POSTN mRNA | CTD | PMID:21198554 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of POSTN mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:1305285 | 6480464 | Dibutyl Phthalate results in increased expression of POSTN mRNA | CTD | PMID:21266533 |
| dioxygen | multiple interactions | EXP | | 6480464 | POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CCL4 mRNA]; more ... | CTD | PMID:22363622 |
| dioxygen | multiple interactions | EXP | | 6480464 | POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of POSTN mRNA] | CTD | PMID:22363622 PMID:22363622 |
| dioxygen | decreases response to substance | EXP | | 6480464 | POSTN gene mutant form results in decreased susceptibility to Oxygen | CTD | PMID:22363622 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen results in increased expression of POSTN mRNA; more ... | CTD | PMID:22363622 |
| doxorubicin | multiple interactions | EXP | | 6480464 | DMD protein affects the reaction [Doxorubicin results in decreased expression of POSTN mRNA] | CTD | PMID:17888722 |
| doxorubicin | multiple interactions | ISO | RGD:1305285 | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of POSTN mRNA] | CTD | PMID:19915844 |
| doxorubicin | increases expression | ISO | RGD:1305285 | 6480464 | Doxorubicin results in increased expression of POSTN mRNA | CTD | PMID:19915844 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of POSTN mRNA | CTD | PMID:17888722 |
| elemental selenium | decreases expression | ISO | RGD:1313223 | 6480464 | Selenium results in decreased expression of POSTN mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA | CTD | PMID:20938992 |
| genistein | decreases expression | ISO | RGD:1305285 | 6480464 | Genistein results in decreased expression of POSTN mRNA | CTD | PMID:12075121 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of POSTN mRNA | CTD | PMID:20003209 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA | CTD | PMID:20938992 |
| losartan | multiple interactions | ISO | RGD:1305285 | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of POSTN mRNA] | CTD | PMID:15121739 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of POSTN mRNA | CTD | PMID:21641384 |
| LY294002 | multiple interactions | ISO | RGD:1305285 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA] | CTD | PMID:16325820 PMID:15121739 |
| LY294002 | multiple interactions | ISO | RGD:1305285 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TGFB1 protein results in increased expression of POSTN mRNA] | CTD | PMID:16325820 |
| LY294002 | multiple interactions | ISO | RGD:1305285 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; more ... | CTD | PMID:15121739 PMID:16325820 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:1305285 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of POSTN mRNA | CTD | PMID:15120970 |
| ochratoxin A | increases expression | ISO | RGD:1305285 | 6480464 | ochratoxin A results in increased expression of POSTN mRNA | CTD | PMID:19717638 |
| paclitaxel | increases expression | ISO | RGD:1313223 | 6480464 | Paclitaxel results in increased expression of POSTN mRNA | CTD | PMID:19682730 |
| paracetamol | decreases expression | ISO | RGD:1313223 | 6480464 | Acetaminophen results in decreased expression of POSTN mRNA | CTD | PMID:21420995 |
| paricalcitol | multiple interactions | ISO | RGD:1313223 | 6480464 | [Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA | CTD | PMID:17715259 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of POSTN mRNA | CTD | PMID:19136022 |
| phenobarbital | decreases expression | ISO | RGD:1313223 | 6480464 | Phenobarbital results in decreased expression of POSTN mRNA | CTD | PMID:19084549 |
| phosphorus atom | multiple interactions | ISO | RGD:1313223 | 6480464 | [Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA | CTD | PMID:17715259 |
| phosphorus(.) | multiple interactions | ISO | RGD:1313223 | 6480464 | [Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA | CTD | PMID:17715259 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of POSTN mRNA | CTD | PMID:19136022 |
| razoxane | multiple interactions | ISO | RGD:1305285 | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of POSTN mRNA] | CTD | PMID:19915844 |
| selenium atom | decreases expression | ISO | RGD:1313223 | 6480464 | Selenium results in decreased expression of POSTN mRNA | CTD | PMID:19244175 |
| sirolimus | multiple interactions | ISO | RGD:1305285 | 6480464 | Sirolimus inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA] | CTD | PMID:15121739 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of POSTN mRNA | CTD | PMID:17555576 |
| valsartan | multiple interactions | ISO | RGD:1305285 | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of POSTN mRNA] | CTD | PMID:17485602 |
| wortmannin | multiple interactions | ISO | RGD:1305285 | 6480464 | wortmannin inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; more ... | CTD | PMID:15121739 |